جهش در ژن «SMAD4» سبب بروز سندرم مییر میگردد که نوعی اختلال ژنتیکی نادر است و که مشخصهاش، ناتوانیهای ذهنی، قد کوتاه، مشخصات غیرطبیعی چهره و چندین ناهنجاری استخوانی است.[۱۱][۱۲] این سندرم نخستین بار در سال ۱۹۸۱ توسط پزشک آمریکایی «سِـلما اِی. مییر» کشف و توصیف شد.
↑Roelen BA, Cohen OS, Raychowdhury MK, Chadee DN, Zhang Y, Kyriakis JM, Alessandrini AA, Lin HY (Oct 2003). "Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-beta-induced nuclear accumulation". American Journal of Physiology. Cell Physiology. 285 (4): C823–30. doi:10.1152/ajpcell.00053.2003. PMID12801888.
↑Demagny H, Araki T, De Robertis EM (Oct 2014). "The tumor suppressor Smad4/DPC4 is regulated by phosphorylations that integrate FGF, Wnt, and TGF-β signaling". Cell Reports. 9 (2): 688–700. doi:10.1016/j.celrep.2014.09.020. PMID25373906.
↑Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. ISBN0-7216-0187-1. {{cite book}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
↑Caputo V, Bocchinfuso G, Castori M, Traversa A, Pizzuti A, Stella L, Grammatico P, Tartaglia M (Jul 2014). "Novel SMAD4 mutation causing Myhre syndrome". American Journal of Medical Genetics Part A. 164A (7): 1835–40. doi:10.1002/ajmg.a.36544. PMID24715504.
Ali S, Cohen C, Little JV, Sequeira JH, Mosunjac MB, Siddiqui MT (Oct 2007). "The utility of SMAD4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors". Diagnostic Cytopathology. 35 (10): 644–8. doi:10.1002/dc.20715. PMID17854080.
Sebestyén A, Hajdu M, Kis L, Barna G, Kopper L (Sep 2007). "Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells". Experimental Cell Research. 313 (15): 3167–74. doi:10.1016/j.yexcr.2007.05.028. PMID17643425.
Grijelmo C, Rodrigue C, Svrcek M, Bruyneel E, Hendrix A, de Wever O, Gespach C (Aug 2007). "Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells". Cellular Signalling. 19 (8): 1722–32. doi:10.1016/j.cellsig.2007.03.008. PMID17478078.
Sheikh AA, Vimalachandran D, Thompson CC, Jenkins RE, Nedjadi T, Shekouh A, Campbell F, Dodson A, Prime W, Crnogorac-Jurcevic T, Lemoine NR, Costello E (Jun 2007). "The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells". Proteomics. 7 (11): 1929–40. doi:10.1002/pmic.200700072. PMID17469085.
Takano S, Kanai F, Jazag A, Ijichi H, Yao J, Ogawa H, Enomoto N, Omata M, Nakao A (Mar 2007). "Smad4 is essential for down-regulation of E-cadherin induced by TGF-beta in pancreatic cancer cell line PANC-1". Journal of Biochemistry. 141 (3): 345–51. doi:10.1093/jb/mvm039. PMID17301079.